K

KeyMed Biosciences Inc
HKEX:2162

Watchlist Manager
KeyMed Biosciences Inc
HKEX:2162
Watchlist
Price: 31.85 HKD -2.3% Market Closed
Market Cap: 8.9B HKD
Have any thoughts about
KeyMed Biosciences Inc?
Write Note

Income Statement

Earnings Waterfall
KeyMed Biosciences Inc

Revenue
81.7m CNY
Cost of Revenue
-25.6m CNY
Gross Profit
56.1m CNY
Operating Expenses
-846.2m CNY
Operating Income
-790.1m CNY
Other Expenses
47.1m CNY
Net Income
-743.1m CNY

Income Statement
KeyMed Biosciences Inc

Rotate your device to view
Income Statement
Currency: CNY
Dec-2021 Jun-2022 Dec-2022 Jun-2023 Dec-2023 Jun-2024
Revenue
Revenue
110
N/A
210
+91%
100
-52%
327
+227%
354
+8%
82
-77%
Gross Profit
Cost of Revenue
(17)
(20)
(3)
(15)
(37)
(26)
Gross Profit
93
N/A
191
+105%
97
-49%
312
+220%
317
+2%
56
-82%
Operating Income
Operating Expenses
(3 910)
(558)
(576)
(700)
(751)
(846)
Selling, General & Administrative
(92)
(117)
(134)
(165)
(177)
(208)
Research & Development
(358)
(331)
(507)
(593)
(596)
(678)
Other Operating Expenses
(3 459)
(110)
65
58
22
39
Operating Income
(3 817)
N/A
(367)
+90%
(479)
-30%
(388)
+19%
(434)
-12%
(790)
-82%
Pre-Tax Income
Interest Income Expense
(60)
96
175
130
77
55
Non-Reccuring Items
(16)
11
0
0
0
0
Total Other Income
0
0
(0)
0
0
0
Pre-Tax Income
(3 893)
N/A
(260)
+93%
(304)
-17%
(258)
+15%
(356)
-38%
(735)
-106%
Net Income
Tax Provision
0
0
0
0
(2)
(8)
Income from Continuing Operations
(3 893)
(260)
(304)
(258)
(358)
(743)
Income to Minority Interest
5
6
(5)
(9)
(2)
(1)
Net Income (Common)
(3 887)
N/A
(253)
+93%
(308)
-22%
(267)
+13%
(359)
-35%
(743)
-107%
EPS (Diluted)
-24.17
N/A
-0.94
+96%
-1.18
-26%
-1
+15%
-1.37
-37%
-2.84
-107%

See Also

Discover More